May 1 is the day DNDN expect FDA news. My guess is that should they get approval that it may spark interest in other Therapeutic Vaccine developers e.g. PRR and VHL. Any thoughts?
ASX Market Open: Australian bourse to fall as subdued Wall Street awaits rate cut decision | September 18, 2024